Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
British Journal of Haematology
|
March 29, 2026
Cyclin D1 immunostaining as a diagnostic surrogate for the t(11;14) translocation in AL amyloidosis
Thomas George, Andrew Staron, Eric J Burks, et al.
Trends in Cancer
|
June 4, 2020
Genomic Instability in Multiple Myeloma
David A Alagpulinsa, Raphael E Szalat, Mark C Poznansky, et al.
American Journal of Hematology
|
November 5, 2021
Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab
Raphael E Szalat, Joshua Gustine, J Mark Sloan, et al.
Haematologica
|
December 22, 2022
Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes
Joshua N Gustine, Raphael E Szalat, Andrew Staron, et al.
Nature Communications
|
May 16, 2024
Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes
Moritz Binder, Raphael E Szalat, Srikanth Talluri, et al.
Breast Cancer Research and Treatment
|
December 12, 2025
Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors
Grace M Ferri, Corina Beiner Martinez, Jose Acevedo, et al.
Journal of the National Cancer Institute
|
October 8, 2020
Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study
Nathanael R Fillmore, Jennifer La, Raphael E Szalat, et al.
Blood Advances
|
August 24, 2021
Lack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA study
Nathanael R Fillmore, Diana Cirstea, Anusha Munjuluri, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 7, 2022
Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study
Nathanael R Fillmore, Raphael E Szalat, Jennifer La, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 27, 2025
When ICAN(S) Becomes ICAN'T: Clinician and Staff Perspectives on In-Hospital Neurotoxicity Grading
Grace M Ferri, Allison Frank, Daniel Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
British Journal of Haematology
|
March 29, 2026
Cyclin D1 immunostaining as a diagnostic surrogate for the t(11;14) translocation in AL amyloidosis
Thomas George, Andrew Staron, Eric J Burks, et al.
Trends in Cancer
|
June 4, 2020
Genomic Instability in Multiple Myeloma
David A Alagpulinsa, Raphael E Szalat, Mark C Poznansky, et al.
American Journal of Hematology
|
November 5, 2021
Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab
Raphael E Szalat, Joshua Gustine, J Mark Sloan, et al.
Haematologica
|
December 22, 2022
Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes
Joshua N Gustine, Raphael E Szalat, Andrew Staron, et al.
Nature Communications
|
May 16, 2024
Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes
Moritz Binder, Raphael E Szalat, Srikanth Talluri, et al.
Breast Cancer Research and Treatment
|
December 12, 2025
Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors
Grace M Ferri, Corina Beiner Martinez, Jose Acevedo, et al.
Journal of the National Cancer Institute
|
October 8, 2020
Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study
Nathanael R Fillmore, Jennifer La, Raphael E Szalat, et al.
Blood Advances
|
August 24, 2021
Lack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA study
Nathanael R Fillmore, Diana Cirstea, Anusha Munjuluri, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 7, 2022
Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study
Nathanael R Fillmore, Raphael E Szalat, Jennifer La, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 27, 2025
When ICAN(S) Becomes ICAN'T: Clinician and Staff Perspectives on In-Hospital Neurotoxicity Grading
Grace M Ferri, Allison Frank, Daniel Li, et al.
Page
of 2